SEGLUROMET

ertugliflozin and metformin hydrochloride · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for SEGLUROMET, covering 2017-12-19 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: SEGLUROMET — Supplemental Application (Merck Sharp & Dohme LLC)